Alambatang, Felipe M.
HRN: 26-30-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2024
CEFTRIAXONE 1G (VIAL)
12/02/2024
12/08/2024
IV DRIP
2g
OD
Fracture Close Complete Distal 3rd Femur Left
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes